1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America and South & Central America Medical Marijuana Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America and South & Central America Medical Marijuana Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Growing acceptance and legalization of medical marijuana for various health conditions and treatments.
- 5.1.3 Increasing awareness among patients and healthcare providers about the therapeutic benefits of cannabis.
- 5.1.4 Rising prevalence of chronic diseases and mental health disorders driving demand for alternative therapies.
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Development of new medical marijuana formulations and delivery methods tailored to specific patient needs.
- 5.2.3 Expansion into international markets where medical cannabis regulations are evolving and becoming more favorable.
- 5.2.4 Opportunities for research and clinical trials to explore additional therapeutic applications of medical marijuana.
5.3 Future Trends
- 5.3.1
- 5.3.2 Increasing focus on personalized medicine and targeted therapies using cannabinoid profiles for specific health conditions.
- 5.3.3 Advancements in cultivation and extraction technologies improving product quality and consistency.
- 5.3.4 Growing emphasis on education and training for healthcare professionals to ensure informed prescribing and patient care.
5.4 Impact of Drivers and Restraints
6. North America and South & Central America Medical Marijuana Market Regional Analysis
6.1 North America and South & Central America Medical Marijuana Market Overview
6.2 North America and South & Central America Medical Marijuana Market Revenue 2019-2028 (US$ Million)
6.3 North America and South & Central America Medical Marijuana Market Forecast Analysis
7. North America and South & Central America Medical Marijuana Market Analysis – by Product Type
7.1 Beans
- 7.1.1 Overview
- 7.1.2 Beans: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Capsules
- 7.2.1 Overview
- 7.2.2 Capsules: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Powder and instant coffee
- 7.3.1 Overview
- 7.3.2 Powder and instant coffee: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)
8. North America and South & Central America Medical Marijuana Market Analysis – by Category
8.1 Organic
- 8.1.1 Overview
- 8.1.2 Organic: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Conventional
- 8.2.1 Overview
- 8.2.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9. North America and South & Central America Medical Marijuana Market Analysis – by Distribution Channel
9.1 Supermarkets and Hypermarkets
- 9.1.1 Overview
- 9.1.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Convenience Stores
- 9.2.1 Overview
- 9.2.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Online Retail
- 9.3.1 Overview
- 9.3.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10. North America and South & Central America Medical Marijuana Market – South and Central America Analysis
10.1 North America
- 10.1.1 North America and South & Central America Medical Marijuana Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America and South & Central America Medical Marijuana Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.1.2 US: North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.1.1.1.3 US: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.1.1.2 Canada:
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.2.2 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.1.1.2.3 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.1.1.3 Mexico :
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.1.1.3.2 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.1.1.3.3 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
10.2 South and Central America
- 10.2.1 North America and South & Central America Medical Marijuana Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America and South & Central America Medical Marijuana Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Brazil:
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.1.2 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.2.1.1.3 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.2.1.2 Argentina:
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.2.2 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.2.1.2.3 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
- 10.2.1.3 Rest of South and Central America :
North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
- 10.2.1.3.2 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Category
- 10.2.1.3.3 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America and South & Central America Medical Marijuana Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Aphria, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Aurora Cannabis Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Canopy Growth Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CanaQuest Medical Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GW Pharmaceuticals
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 The Green Organic Dutchman Holdings
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Cannabis Science, Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 CANVORY
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Organigram Holdings Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Tikun Olam
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America and South & Central America Medical Marijuana Market
